Requirement of tumor-associated antigen-specific CD4 + T cells for an efficient dendritic cell vaccine in antitumor immunotherapy

By Simon Thomas   Fonteneau Jean-François   Grégoire Marc  

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 565-567

Future Medicine

Access to resources Recommend Favorite

CD16 + and CD16 − human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4 + T cells

By Sánchez-Torres Carmen   García-Romo Gina S.   Cornejo-Cortés Miguel A.   Rivas-Carvalho Amaranta  

International Immunology, Vol. 13, Iss. 12, 2001-12 ,pp. : 1571-1581

Oxford University Press

Access to resources Recommend Favorite

Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell‐mediated anti‐CD83‐dependent cytotoxicity

By Munster David J.   MacDonald Kelli P. A.   Kato Masato   Hart Derek J. N.  

International Immunology, Vol. 16, Iss. 1, 2004-01 ,pp. : 33-42

Oxford University Press

Access to resources Recommend Favorite

The role of LIGHT in T cell-mediated immunity

By Wang Jing   Fu Yang-Xin  

Immunologic Research, Vol. 30, Iss. 2, 2004-10 ,pp. : 201-214

Humana Press, Inc

Access to resources Recommend Favorite

Neonatal human autologous dendritic cells pulsed with recombinant protein antigen prime the generation of non-polarized CD4 T-cell effectors

By Matthews Nick C.   Power Ultan F.   Reen Denis J.  

International Immunology, Vol. 19, Iss. 6, 2007-06 ,pp. : 703-712

Oxford University Press

Access to resources Recommend Favorite